Visit https://www.peervoice.com/FYS860 to view the entire programme with slides. After completing “The Case for New Combinations in Relapsed Multiple Myeloma: Finding the Perfect Therapeutic Fit for Your High-Risk Patient”, participants will be able to: Apply the latest evidence to the management of patients with relapsed MM with high-risk cytogenetics.